A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria
TP53 mutations are associated with distinct clinicopathological and prognostic features which warrants a separate entity apart from AML-MR.AML with myelody